1. Home
  2. GSIW vs NOTV Comparison

GSIW vs NOTV Comparison

Compare GSIW & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSIW

Garden Stage Limited

HOLD

Current Price

$0.15

Market Cap

33.9M

Sector

N/A

ML Signal

HOLD

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.83

Market Cap

29.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSIW
NOTV
Founded
2016
1974
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.9M
29.9M
IPO Year
2023
1997

Fundamental Metrics

Financial Performance
Metric
GSIW
NOTV
Price
$0.15
$0.83
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
402.2K
1.6M
Earning Date
01-01-0001
12-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,368,221.00
$513,024,000.00
Revenue This Year
N/A
$6.26
Revenue Next Year
N/A
$45.49
P/E Ratio
N/A
N/A
Revenue Growth
283.23
4.54
52 Week Low
$0.09
$0.66
52 Week High
$1.79
$6.48

Technical Indicators

Market Signals
Indicator
GSIW
NOTV
Relative Strength Index (RSI) 45.84 37.84
Support Level $0.14 $0.79
Resistance Level $0.15 $0.95
Average True Range (ATR) 0.01 0.09
MACD 0.00 0.01
Stochastic Oscillator 50.86 52.03

Price Performance

Historical Comparison
GSIW
NOTV

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: